STOCK TITAN

Tandem Diabetes Care: Balyasny reports about 5.21%

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Tandem Diabetes Care, Inc. (TNDM) is the subject of a Schedule 13G reporting that five reporting persons may each be deemed beneficial owners of 3,624,727 common shares, or approximately 5.21% of the class. The same shares are held directly by Atlas Diversified Master Fund, Ltd. (ADMF).

The reporting persons are Balyasny Asset Management L.P., BAM GP LLC, Balyasny Asset Management Holdings LP, Dames GP LLC and Dmitry Balyasny, the managing member of Dames. The reported percentage is based on 69,578,707 shares outstanding as of August 3, 2026. ADMF has the right to receive dividends and sale proceeds from the shares.

Beneficially owned shares 3,624,727 shares The same shares are reported by each of the five reporting persons and are held directly by ADMF.
Percent of class approximately 5.21% Based on 69,578,707 shares outstanding as of August 3, 2026.
Shares outstanding 69,578,707 shares As of August 3, 2026.
beneficially own regulatory
"may be deemed to beneficially own such Shares"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
sole power to vote regulatory
"sole power to vote or to direct the vote"
sole power to dispose regulatory
"sole power to dispose or to direct the disposition"
investment manager regulatory
"its position as the investment manager of ADMF"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many TNDM shares do the Schedule 13G reporting persons report?

The five reporting persons each may be deemed beneficial owners of 3,624,727 shares, approximately 5.21% of the class.

Who directly holds the TNDM shares reported by Balyasny?

Atlas Diversified Master Fund, Ltd. (ADMF) directly holds the shares and has the right to receive dividends and proceeds from their sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





875372203

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



BALYASNY ASSET MANAGEMENT L.P.
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
BAM GP LLC
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
Balyasny Asset Management Holdings LP
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
Dames GP LLC
Signature:/s/ Scott Schroeder
Name/Title:Scott Schroeder / Authorized Signatory
Date:11/16/2026
Dmitry Balyasny
Signature:/s/ Dmitry Balyasny
Name/Title:Dmitry Balyasny / Self
Date:11/16/2026

Keep reading